Avidity Partners Management LP
Top Portfolio Positions
46 positions ·
$395,825,148 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
2,104,184 | $176,583,121 | 44.61% |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
760,424 | $37,298,797 | 9.42% |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
6,049,999 | $25,228,495 | 6.37% |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
1,400,708 | $19,679,947 | 4.97% |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
400,000 | $15,680,000 | 3.96% |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
4,998,267 | $13,095,459 | 3.31% |
| RGEN |
Repligen Corp
Healthcare
|
77,800 | $9,166,396 | 2.32% |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
70,000 | $8,725,500 | 2.20% |
| MDT |
Medtronic plc
Healthcare
|
100,000 | $8,665,000 | 2.19% |
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
468,566 | $8,382,645 | 2.12% |
Portfolio Trend
Holdings in DNTH
Shares Held
Position Value (USD)
11 of 11 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $176,583,121 | 2,104,184 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $86,713,422 | 2,104,184 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $126,084,640 | 3,204,184 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $32,470,264 | 1,742,902 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,217,162 | 1,720,902 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $62,631,400 | 2,873,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $79,873,784 | 2,917,231 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $75,497,938 | 2,917,231 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $81,526,620 | 2,717,554 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,662,561 | 1,217,554 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,643,963 | 1,217,554 | Shares | Sole | 2023-11-14 | |
| No quarters match your search. | ||||||